Eli Lilly is developing a groundbreaking drug, lepodisiran, to combat high LPA cholesterol levels prevalent in South Asians, ...

Eli Lilly is exploring partnerships with Indian pharma firms to market its anti-diabetes and weight loss drug Mounjaro, ...

Mounjaro, a weight loss drug launched by Eli Lilly in India, could be a game-changer and has been making waves lately. Here's ...

Unlike the US, Europe or other developed markets, Mounjaro will have to be purchased out-of-pocket in India, as obesity is ...

Embassy Office Parks REIT offers strong dividend yield, capital appreciation potential and steady rental growth in commercial ...

GCCs in life sciences and healthcare have grown across India, with Bengaluru, Hyderabad, and Chennai emerging as key hubs ...

Eli Lilly’s Global CEO David Ricks revealed that the pharma giant might manufacture its weight-loss blockbuster, Mounjaro, in ...

Talent Acquisition and Retention Pose Major Challenges for Life Sciences GCCs - Talent retention and acquisition are top ...

Diabetes cases could surge to 124 million by 2045, and nearly a quarter of Indian adults are already overweight or obese.